Until recently, the federal government did not require hospitals to report the number of doses they administered to patients, although it will begin to do so from January 8. who offers the treatments.
Dr Skovronsky said patients who call Eli Lilly’s hotline eventually get the treatments. “But that’s not fair,” he said. “It shouldn’t be just for people who are persistent, know how to call and have doctors to get it. It should be for everyone.
Doctors and hospital officials said factors that have hampered the U.S. response to the coronavirus have also hampered the delivery of antibody treatments.
Every day in Green Bay, Wisconsin, doctors from Prevea Health, a large state medical practice, call in high-risk patients tested in the state to suggest treatments. But federal testing sites don’t share patient information, making it difficult to reach people who might benefit.
“We haven’t done a very good job – nationally, locally, anywhere – reaching out to these high-risk populations and saying, ‘Hey, if you’re starting to feel sick, we’ve got to know that. right away, ”said Dr Ashok Rai, President and CEO of Prevea Health.
Despite the obstacles, Dr Rai said Prevea has made progress. Earlier in the pandemic, the intensive care unit at one of its partner hospitals, HSHS St. Vincent, quickly filled up in the event of an outbreak in long-term care facilities. But since the treatments became available, workers have rushed to administer them at two assisted living centers, reducing the number of hospital patients.
“It’s palpable in our numbers right now,” Dr Rai said.
Another challenge is finding the space and staff members to administer the treatments safely. In Rome, Georgia, Floyd Medical Center has refitted several rooms in the ward for Covid-19 hospital patients for infusions. And as Floyd downsized, nurses sometimes had to work late to administer treatments, said Dr Daniel Valancius, who heads the hospital’s monoclonal antibody program.